(Q35806751)

10 August 2017

1 reference

title

Role of COX-2 inhibitors in cancer therapy (English)

1 reference

10 August 2017

Charles Blanke

1

1 reference

10 August 2017

publication date

1 January 2004

1 reference

10 August 2017

1 reference

10 August 2017

volume

22

1 reference

10 August 2017

issue

2

1 reference

10 August 2017

page(s)

271-282

1 reference

Isolation and Structure of Two Prostaglandin Endoperoxides That Cause Platelet Aggregation

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Arachidonic acid metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Prostaglandin endoperoxide synthase gene structure: identification of the transcriptional start site and 5'-flanking regulatory sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Structure of the human cyclo-oxygenase-2 gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Effects of transforming growth factor beta and interleukin-1 beta on expression of cyclooxygenase 1 and 2 and phospholipase A2 mRNA in lung fibroblasts and endothelial cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Cyclooxygenase-2 inhibitor ns-398 protects neuronal cultures from lipopolysaccharide-induced neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Platelet-derived growth factor stimulates phospholipase C-gamma 1, extracellular signal-regulated kinase, and arachidonic acid release in rat myometrial cells: contribution to cyclic 3',5'-adenosine monophosphate production and effect on cell prolif

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Adrenergic stimulation of osteoclastogenesis mediated by expression of osteoclast differentiation factor in MC3T3-E1 osteoblast-like cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Prostaglandin E(2) increases bovine leukemia virus tax and pol mRNA levels via cyclooxygenase 2: regulation by interleukin-2, interleukin-10, and bovine leukemia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of COX-2 and interleukin 6 in rat adjuvant arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

The role of cyclooxygenase enzymes in the growth of human gall bladder cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Differential expression of cyclooxygenase-2 (COX-2) in human bile duct epithelial cells and bile duct neoplasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Cyclooxygenase-2 expression and prostaglandin E(2) synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Relation between cyclooxygenase-2 expression and tumor invasiveness and patient survival in transitional cell carcinoma of the urinary bladder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Immunohistochemical expression of cyclooxygenase-2 in skin cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Cyclooxygenase-2: a target for the prevention and treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

The role of cyclooxygenase-2 in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

The relationship between cyclooxygenase-2 expression and colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Tumor invasiveness and liver metastasis of colon cancer cells correlated with cyclooxygenase-2 (COX-2) expression and inhibited by a COX-2-selective inhibitor, etodolac.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Nonsteroidal anti-inflammatory drugs, eicosanoids, and colorectal cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Aspirin use and chronic diseases: a cohort study of the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Colorectal cancer prevention by non-steroidal anti-inflammatory drugs: effects of dosage and timing

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

A protective effect of sulindac against chemically-induced primary colonic tumours in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Mechanism of inhibition of tumour growth by aspirin and indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Alteration of tumor growth by aspirin and indomethacin: studies with two transplantable tumors in mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl] formamide-induced bladder carcinogenesis and enhancement of forestomach carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

A comparison of the effects of the prostaglandin synthesis inhibitors indomethacin and carprofen on 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis in rats fed different amounts of essential fatty acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Sulindac for polyposis of the colon.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Cyclooxygenase regulates angiogenesis induced by colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Suppression of vascular endothelial growth factor-mediated endothelial cell protection by survivin targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Prostaglandin E2 increases growth and motility of colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Detection of differentially expressed genes in human colon carcinoma cells treated with a selective COX-2 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Activation of the PPAR pathway induces apoptosis and COX-2 inhibition in HT-29 human colon cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Induction of apoptosis by cyclooxygenase-2 inhibitors in prostate cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Specific inhibition of cyclooxygenase 2 restores antitumor reactivity by altering the balance of IL-10 and IL-12 synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Cyclooxygenase-2 inhibitors: a new class of anti-inflammatory agents that spare the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Risk of cardiovascular events associated with selective COX-2 inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Cyclooxygenase-2 (COX-2) enzyme inhibitors as potential enhancers of tumor radioresponse

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Targeting angiogenic processes by combination rofecoxib and ionizing radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Selective inhibition of cyclooxygenase-2 enhances mitomycin-C-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Phospholipid precursors of prostaglandins

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Interleukin-1-Induced Prostaglandin E2 Biosynthesis in Human Synovial Cells Involves the Activation of Cytosolic Phospholipase A2 and Cyclooxygenase-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Regulation of cyclooxygenase-2 by interferon gamma and transforming growth factor alpha in normal human epidermal keratinocytes and squamous carcinoma cells. Role of mitogen-activated protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Expression of cyclooxygenase-2 in human gastric adenomas and adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Inhibition of cyclooxygenase-2 expression. An approach to preventing head and neck cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Preliminary report: Findings from the aspirin component of the ongoing Physicians' Health Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Effects of Long-term Sulindac Therapy on Colonic Polyposis

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

21 January 2018

PGE2 and angiogenesis

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Is the COX-2 effect on accelerated hematopoiesis mediated by prostaglandin E2?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

Radiation induces upregulation of cyclooxygenase-2 (COX-2) protein in PC-3 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FCNV-120030216

21 January 2018

Identifiers

DOI

10.1081/CNV-120030216

1 reference

10 August 2017

1 reference